Number of the records: 1
FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
- 1.ŠTEFÁNIK, M., VALDÉS, J. J., EZEBUO, F.C., HAVIERNIK, J., UZOCHUKWU, I.C., FOJTIKOVÁ, M., SALÁT, J., EYER, L., RŮŽEK, D. FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms. 2020, 8(4), 599. E-ISSN 2076-2607. Available: doi: 10.3390/microorganisms8040599.
Number of the records: 1